These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34078216)

  • 1. Protective effects of repetitive transcranial magnetic stimulation against 6-OHDA-induced Parkinson's symptoms in a mice model: the key role of miR-409-3p/PDHB axis.
    Wang H; Gao H
    Int J Neurosci; 2023 May; 133(5):578-585. PubMed ID: 34078216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repetitive transcranial magnetic stimulation protects mice against 6-OHDA-induced Parkinson's disease symptoms by regulating brain amyloid β
    Ba F; Zhou Y; Zhou J; Chen X
    Mol Cell Biochem; 2019 Aug; 458(1-2):71-78. PubMed ID: 31004306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of rTMS Alleviates Stroke-Induced Cognitive Deficits by Modulating miR-409-3p/CTRP3/AMPK/Sirt1 Axis.
    Wu T; Tang C; Fan J; Tao J
    J Mol Neurosci; 2022 Mar; 72(3):507-515. PubMed ID: 34655390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repetitive Transcranial Magnetic Stimulation Improves Mild Cognitive Impairment Associated with Alzheimer's Disease in Mice by Modulating the miR-567/NEUROD2/PSD95 Axis.
    Pang Y; Shi M
    Neuropsychiatr Dis Treat; 2021; 17():2151-2161. PubMed ID: 34239303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repetitive Transcranial Magnetic Stimulation Reduces Neuronal Loss and Neuroinflammation in Parkinson?s Disease Through the miR-195a-5p/CREB Axis.
    Sun L; Wang F; Han J; Bai L; DU J
    Turk Neurosurg; 2023; 33(2):229-237. PubMed ID: 36300577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of repetitive transcranial magnetic stimulation in an animal model of Parkinson's disease.
    Lee JY; Kim SH; Ko AR; Lee JS; Yu JH; Seo JH; Cho BP; Cho SR
    Brain Res; 2013 Nov; 1537():290-302. PubMed ID: 23998987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive transcranial magnetic stimulation alleviates glial activation through suppressing HMGB1/TLR4 pathway in a rat model of Parkinson's disease.
    Han C; Zhang X; Dou K; Yao W; Yao M; Wan Q; Xie A
    Mol Biol Rep; 2023 Aug; 50(8):6481-6492. PubMed ID: 37328582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of repetitive transcranial magnetic stimulation on a model rat of Parkinson's disease.
    Yang X; Song L; Liu Z
    Neuroreport; 2010 Mar; 21(4):268-72. PubMed ID: 20087233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of Human Mesenchymal Stem Cells and Repetitive Transcranial Magnetic Stimulation Enhances Neurological Recovery of 6-Hydroxydopamine Model of Parkinsonian's Disease.
    Lee JY; Kim HS; Kim SH; Kim HS; Cho BP
    Tissue Eng Regen Med; 2020 Feb; 17(1):67-80. PubMed ID: 31970698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mechanism of SNHG8/Microrna-421-3p/Sorting Nexin 8 Axis on Dopaminergic Neurons in Substantia Nigra in a Mouse Model of Parkinson's Disease.
    Zhou S; Zhou X; Jiang Z; Ma J; Li Y; Qian Z; Li H
    Neurochem Res; 2023 Mar; 48(3):942-955. PubMed ID: 36401052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA miR-17-92a-1 cluster host gene (MIR17HG) promotes neuronal damage and microglial activation by targeting the microRNA-153-3p/alpha-synuclein axis in Parkinson's disease.
    Zhang J; Yang Y; Zhou C; Zhu R; Xiao X; Zhou B; Wan D
    Bioengineered; 2022 Feb; 13(2):4493-4516. PubMed ID: 35137671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson's disease by elevating NPTX2
    Lang Y; Li Y; Yu H; Lin L; Chen X; Wang S; Zhang H
    Aging (Albany NY); 2020 May; 12(9):7660-7678. PubMed ID: 32396526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Frequency Repetitive Transcranial Magnetic Stimulation Regulates Astrocyte Activation by Modulating the Endocannabinoid System in Parkinson's Disease.
    Kang X; Zhang B; Du W; Zhao R; Liu X; Bai Y; Jiang X; Pang J; Zhao C; Mou X; Gao F; Yuan H; Sun X
    Mol Neurobiol; 2022 Aug; 59(8):5121-5134. PubMed ID: 35672602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Repetitive Transcranial Magnetic Stimulation Exerts Neuroprotective Effects and Improves Motor Functions in Hemiparkinsonian Rats.
    Hsieh TH; He XK; Liu HH; Chen JJ; Peng CW; Liu HL; Rotenberg A; Chen KT; Chang MY; Chiang YH; Chang PK; Kuo CW
    Neural Plast; 2021; 2021():1763533. PubMed ID: 34987572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA H19 diminishes dopaminergic neuron loss by mediating microRNA-301b-3p in Parkinson's disease via the HPRT1-mediated Wnt/β-catenin signaling pathway.
    Jiang J; Piao X; Hu S; Gao J; Bao M
    Aging (Albany NY); 2020 May; 12(10):8820-8836. PubMed ID: 32434961
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zhai K; Liu B; Gao L
    Hum Gene Ther; 2020 Dec; 31(23-24):1274-1287. PubMed ID: 32808542
    [No Abstract]   [Full Text] [Related]  

  • 17. LncRNA DLX6-AS1 promotes microglial inflammatory response in Parkinson's disease by regulating the miR-223-3p/NRP1 axis.
    Liu L; Zhou T; Li T; Liang Z; Luo X
    Behav Brain Res; 2022 Aug; 431():113923. PubMed ID: 35550840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-193b-3p/ PGC-1α pathway regulates an insulin dependent anti-inflammatory response in Parkinson's disease.
    Mesarosova L; Scheper M; Iyer A; Anink JJ; Mills JD; Aronica E
    Neurobiol Dis; 2024 Sep; 199():106587. PubMed ID: 38950713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-frequency repetitive transcranial magnetic stimulation over the primary foot motor area in Parkinson's disease.
    Maruo T; Hosomi K; Shimokawa T; Kishima H; Oshino S; Morris S; Kageyama Y; Yokoe M; Yoshimine T; Saitoh Y
    Brain Stimul; 2013 Nov; 6(6):884-91. PubMed ID: 23769414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA myocardial infarction-associated transcript promotes 1-Methyl-4-phenylpyridinium ion-induced neuronal inflammation and oxidative stress in Parkinson's disease through regulating microRNA-221-3p/ transforming growth factor /nuclear factor E2-related factor 2 axis.
    Lang Y; Zhang H; Yu H; Li Y; Liu X; Li M
    Bioengineered; 2022 Jan; 13(1):930-940. PubMed ID: 34967706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.